11-13492716-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000315.4(PTH):c.87-50G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.316 in 1,613,372 control chromosomes in the GnomAD database, including 85,603 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 6236 hom., cov: 32)
Exomes 𝑓: 0.32 ( 79367 hom. )
Consequence
PTH
NM_000315.4 intron
NM_000315.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.298
Genes affected
PTH (HGNC:9606): (parathyroid hormone) This gene encodes a member of the parathyroid family of proteins. The encoded preproprotein is proteolytically processed to generate a protein that binds to the parathyroid hormone/parathyroid hormone-related peptide receptor and regulates blood calcium and phosphate levels. Excess production of the encoded protein, known as hyperparathyroidism, can result in hypercalcemia and kidney stones. On the other hand, defective processing of the encoded protein may lead to hypoparathyroidism, which can result in hypocalcemia and numbness. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-13492716-C-T is Benign according to our data. Variant chr11-13492716-C-T is described in ClinVar as [Benign]. Clinvar id is 1289830.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.348 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.261 AC: 39613AN: 151932Hom.: 6240 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
39613
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.283 AC: 70884AN: 250436 AF XY: 0.286 show subpopulations
GnomAD2 exomes
AF:
AC:
70884
AN:
250436
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.321 AC: 469593AN: 1461322Hom.: 79367 Cov.: 42 AF XY: 0.319 AC XY: 231828AN XY: 726924 show subpopulations
GnomAD4 exome
AF:
AC:
469593
AN:
1461322
Hom.:
Cov.:
42
AF XY:
AC XY:
231828
AN XY:
726924
Gnomad4 AFR exome
AF:
AC:
2746
AN:
33474
Gnomad4 AMR exome
AF:
AC:
9990
AN:
44594
Gnomad4 ASJ exome
AF:
AC:
7894
AN:
26128
Gnomad4 EAS exome
AF:
AC:
4139
AN:
39694
Gnomad4 SAS exome
AF:
AC:
16777
AN:
86240
Gnomad4 FIN exome
AF:
AC:
21461
AN:
53364
Gnomad4 NFE exome
AF:
AC:
387251
AN:
1111694
Gnomad4 Remaining exome
AF:
AC:
17767
AN:
60366
Heterozygous variant carriers
0
19407
38814
58221
77628
97035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
12012
24024
36036
48048
60060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.261 AC: 39612AN: 152050Hom.: 6236 Cov.: 32 AF XY: 0.261 AC XY: 19398AN XY: 74316 show subpopulations
GnomAD4 genome
AF:
AC:
39612
AN:
152050
Hom.:
Cov.:
32
AF XY:
AC XY:
19398
AN XY:
74316
Gnomad4 AFR
AF:
AC:
0.0928692
AN:
0.0928692
Gnomad4 AMR
AF:
AC:
0.258453
AN:
0.258453
Gnomad4 ASJ
AF:
AC:
0.299135
AN:
0.299135
Gnomad4 EAS
AF:
AC:
0.11668
AN:
0.11668
Gnomad4 SAS
AF:
AC:
0.19411
AN:
0.19411
Gnomad4 FIN
AF:
AC:
0.421332
AN:
0.421332
Gnomad4 NFE
AF:
AC:
0.351243
AN:
0.351243
Gnomad4 OTH
AF:
AC:
0.257116
AN:
0.257116
Heterozygous variant carriers
0
1373
2745
4118
5490
6863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
404
808
1212
1616
2020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
543
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at